• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组蛋白 H3K9 和 H3K14 在 LGALS9 基因启动子上的乙酰化与宫颈癌细胞中的 mRNA 水平相关。

Histone H3K9 and H3K14 acetylation at the promoter of the LGALS9 gene is associated with mRNA levels in cervical cancer cells.

机构信息

Laboratorio de Biología Molecular, Centro de Investigación Biomédica de Oriente, Instituto Mexicano del Seguro Social, Metepec, Puebla, México.

Posgrado en Ciencias Químicas, Instituto de Ciencias, Benemérita Universidad Autónoma de Puebla, Puebla, México.

出版信息

FEBS Open Bio. 2020 Nov;10(11):2305-2315. doi: 10.1002/2211-5463.12973. Epub 2020 Sep 24.

DOI:10.1002/2211-5463.12973
PMID:32902187
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7609790/
Abstract

Galectin-9 levels have been reported to be altered in several cancer types, but the mechanism that regulates the expression of Galectin-9 has not been clarified. Galectin-9 is encoded by the LGALS9 gene, which gives rise to eight mRNA variants. The aims of this study were: (a) to identify the mRNA variants of LGALS9, (b) to characterize CpG methylation and H3K9 and H3K14 histone acetylation at the promoter of the LGALS9 gene, and (c) to characterize the relationship between these modifications and LGALS9 expression level in cervical cancer cells. All mRNA variants were detected in HaCaT (nontumoural keratinocytes) and SiHa cells, and seven were observed in HeLa cells. The promoter region of LGALS9 contains eight CpG dinucleotides. No hypermethylation pattern related to low LGALS9 expression was identified in tumour cells. Chromatin immunoprecipitation analysis demonstrated higher acetylation of H3K9ac and H3K14ac in HaCaT cells, which was related to higher mRNA levels. The presence of the mRNA variants suggests that alternative splicing may regulate the expression of galectin-9 isoforms. The results of this study suggest that histone acetylation, but not promoter CpG methylation, may be involved in the transcriptional regulation of the LGALS9 gene.

摘要

半乳糖凝集素-9(Galectin-9)水平在几种癌症类型中被报道发生改变,但调节 Galectin-9 表达的机制尚未阐明。Galectin-9 由 LGALS9 基因编码,该基因产生 8 种 mRNA 变体。本研究的目的是:(a)鉴定 LGALS9 的 mRNA 变体,(b)描述 LGALS9 基因启动子处的 CpG 甲基化以及 H3K9 和 H3K14 组蛋白乙酰化,(c)描述这些修饰与宫颈癌细胞中 LGALS9 表达水平之间的关系。所有 mRNA 变体均在 HaCaT(非肿瘤角质形成细胞)和 SiHa 细胞中检测到,在 HeLa 细胞中观察到 7 种变体。LGALS9 的启动子区域含有 8 个 CpG 二核苷酸。在肿瘤细胞中未发现与 LGALS9 低表达相关的高甲基化模式。染色质免疫沉淀分析表明,HaCaT 细胞中 H3K9ac 和 H3K14ac 的乙酰化水平更高,这与更高的 mRNA 水平相关。mRNA 变体的存在表明,选择性剪接可能调节半乳糖凝集素-9 同工型的表达。本研究结果表明,组蛋白乙酰化而不是启动子 CpG 甲基化可能参与 LGALS9 基因的转录调控。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/592c34907af0/FEB4-10-2305-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/74d7defe3a72/FEB4-10-2305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/3e6dd585575a/FEB4-10-2305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/60ca39532af1/FEB4-10-2305-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/da77dba44b6c/FEB4-10-2305-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/da4a7dcb65a6/FEB4-10-2305-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/592c34907af0/FEB4-10-2305-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/74d7defe3a72/FEB4-10-2305-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/3e6dd585575a/FEB4-10-2305-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/60ca39532af1/FEB4-10-2305-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/da77dba44b6c/FEB4-10-2305-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/da4a7dcb65a6/FEB4-10-2305-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a2ee/7609790/592c34907af0/FEB4-10-2305-g006.jpg

相似文献

1
Histone H3K9 and H3K14 acetylation at the promoter of the LGALS9 gene is associated with mRNA levels in cervical cancer cells.组蛋白 H3K9 和 H3K14 在 LGALS9 基因启动子上的乙酰化与宫颈癌细胞中的 mRNA 水平相关。
FEBS Open Bio. 2020 Nov;10(11):2305-2315. doi: 10.1002/2211-5463.12973. Epub 2020 Sep 24.
2
Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma.黑色素瘤中 TIM-3(HAVCR2)和半乳糖凝集素 9(LGALS9)mRNA 表达及 DNA 甲基化的分子和免疫相关性。
Clin Epigenetics. 2019 Nov 20;11(1):161. doi: 10.1186/s13148-019-0752-8.
3
H3K9 and H3K14 acetylation co-occur at many gene regulatory elements, while H3K14ac marks a subset of inactive inducible promoters in mouse embryonic stem cells.H3K9 和 H3K14 的乙酰化在许多基因调控元件中共现,而 H3K14ac 标记了小鼠胚胎干细胞中一组无活性诱导启动子的子集。
BMC Genomics. 2012 Aug 24;13:424. doi: 10.1186/1471-2164-13-424.
4
Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer.组蛋白修饰和 DNA 甲基化之间的串扰调控了宫颈癌中 costimulatory factors,Tim-3 和 galectin-9 的表观遗传调控。
Oncol Rep. 2019 Dec;42(6):2655-2669. doi: 10.3892/or.2019.7388. Epub 2019 Oct 24.
5
Analyzing epigenetic control of galectin expression indicates silencing of galectin-12 by promoter methylation in colorectal cancer.分析表观遗传调控半乳糖凝集素表达表明结直肠癌中半乳糖凝集素-12 的启动子甲基化沉默。
IUBMB Life. 2017 Dec;69(12):962-970. doi: 10.1002/iub.1690. Epub 2017 Nov 3.
6
Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.组蛋白乙酰化和甲基化CpG结合蛋白对O6-甲基鸟嘌呤-DNA甲基转移酶基因表达的表观遗传调控。
Mol Cancer Ther. 2005 Jan;4(1):61-9.
7
Heterogeneous epigenetic regulation of TIMP3 in prostate cancer.前列腺癌中 TIMP3 的异质性表观遗传调控。
Epigenetics. 2012 Nov;7(11):1279-89. doi: 10.4161/epi.22333. Epub 2012 Sep 28.
8
Endothelial LGALS9 splice variant expression in endothelial cell biology and angiogenesis.内皮细胞中LGALS9剪接变体在内皮细胞生物学和血管生成中的表达
Biochim Biophys Acta. 2014 Feb;1842(2):284-92. doi: 10.1016/j.bbadis.2013.12.003. Epub 2013 Dec 12.
9
Altered chromatin structure associated with methylation-induced gene silencing in cancer cells: correlation of accessibility, methylation, MeCP2 binding and acetylation.癌细胞中与甲基化诱导的基因沉默相关的染色质结构改变:可及性、甲基化、MeCP2结合与乙酰化的相关性
Nucleic Acids Res. 2001 Nov 15;29(22):4598-606. doi: 10.1093/nar/29.22.4598.
10
Influence of epigenetic modifications of the interleukin-10 promoter on IL10 gene expression.白细胞介素-10启动子的表观遗传修饰对IL10基因表达的影响。
Eur J Oral Sci. 2012 Feb;120(1):14-20. doi: 10.1111/j.1600-0722.2011.00917.x.

引用本文的文献

1
H3K14: A histone site closely related to diseases.H3K14:一个与疾病密切相关的组蛋白位点。
J Cancer. 2025 Jul 28;16(11):3537-3550. doi: 10.7150/jca.118273. eCollection 2025.
2
Exploring MPC1 as a potential ferroptosis-linked biomarker in the cervical cancer tumor microenvironment: a comprehensive analysis.探索 MPC1 作为宫颈癌肿瘤微环境中潜在的铁死亡相关生物标志物:全面分析。
BMC Cancer. 2024 Oct 10;24(1):1258. doi: 10.1186/s12885-024-12622-x.
3
Diversity of post-translational modifications and cell signaling revealed by single cell and single organelle mass spectrometry.

本文引用的文献

1
Crosstalk between histone modification and DNA methylation orchestrates the epigenetic regulation of the costimulatory factors, Tim‑3 and galectin‑9, in cervical cancer.组蛋白修饰和 DNA 甲基化之间的串扰调控了宫颈癌中 costimulatory factors,Tim-3 和 galectin-9 的表观遗传调控。
Oncol Rep. 2019 Dec;42(6):2655-2669. doi: 10.3892/or.2019.7388. Epub 2019 Oct 24.
2
Promoter DNA hypermethylation - Implications for Alzheimer's disease.启动子 DNA 高甲基化——对阿尔茨海默病的影响。
Neurosci Lett. 2019 Oct 15;711:134403. doi: 10.1016/j.neulet.2019.134403. Epub 2019 Jul 24.
3
Inactivation of SMARCA2 by promoter hypermethylation drives lung cancer development.
单细胞和细胞器质谱揭示的翻译后修饰和细胞信号的多样性。
Commun Biol. 2024 Jul 19;7(1):884. doi: 10.1038/s42003-024-06579-7.
4
Simultaneous targeting of Tim3 and A2a receptors modulates MSLN-CAR T cell antitumor function in a human cervical tumor xenograft model.同时靶向 Tim3 和 A2a 受体可调节 MSLN-CAR T 细胞在人宫颈肿瘤异种移植模型中的抗肿瘤功能。
Front Immunol. 2024 May 24;15:1362904. doi: 10.3389/fimmu.2024.1362904. eCollection 2024.
5
Ferroptosis-related lncRNAs guiding osteosarcoma prognosis and immune microenvironment.铁死亡相关 lncRNAs 指导骨肉瘤预后和免疫微环境。
J Orthop Surg Res. 2023 Oct 19;18(1):787. doi: 10.1186/s13018-023-04286-3.
6
γ-Secretase Inhibitor Potentiates the Activity of Suberoylanilide Hydroxamic Acid by Inhibiting Its Ability to Induce Epithelial to Mesenchymal Transition and Stemness via Notch Pathway Activation in Triple-Negative Breast Cancer Cells.γ-分泌酶抑制剂通过抑制其在三阴性乳腺癌细胞中经由Notch信号通路激活诱导上皮-间质转化和干性的能力,增强了辛二酰苯胺异羟肟酸的活性。
ACS Pharmacol Transl Sci. 2023 Sep 5;6(10):1396-1415. doi: 10.1021/acsptsci.3c00099. eCollection 2023 Oct 13.
7
Implications of Transglutaminase-Mediated Protein Serotonylation in the Epigenetic Landscape, Small Cell Lung Cancer, and Beyond.转谷氨酰胺酶介导的蛋白质5-羟色胺化在表观遗传格局、小细胞肺癌及其他方面的意义
Cancers (Basel). 2023 Feb 20;15(4):1332. doi: 10.3390/cancers15041332.
8
Differential regulation of H3K9/H3K14 acetylation by small molecules drives neuron-fate-induction of glioma cell.小分子对 H3K9/H3K14 乙酰化的差异调节驱动胶质瘤细胞的神经元命运诱导。
Cell Death Dis. 2023 Feb 20;14(2):142. doi: 10.1038/s41419-023-05611-8.
9
Serum Levels of Galectin-9 are Increased in Cervical Cancer Patients and are Higher in Advanced Clinical Stages.宫颈癌患者血清半乳糖凝集素-9水平升高,且在临床晚期更高。
Onco Targets Ther. 2022 Oct 13;15:1211-1220. doi: 10.2147/OTT.S378933. eCollection 2022.
10
Assessment of alterations in histone modification function and guidance for death risk prediction in cervical cancer patients.宫颈癌患者组蛋白修饰功能改变的评估及死亡风险预测指导
Front Genet. 2022 Sep 19;13:1013571. doi: 10.3389/fgene.2022.1013571. eCollection 2022.
启动子甲基化导致 SMARCA2 失活,从而驱动肺癌的发生。
Gene. 2019 Mar 1;687:193-199. doi: 10.1016/j.gene.2018.11.032. Epub 2018 Nov 14.
4
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries.全球癌症统计数据 2018:GLOBOCAN 对全球 185 个国家/地区 36 种癌症的发病率和死亡率的估计。
CA Cancer J Clin. 2018 Nov;68(6):394-424. doi: 10.3322/caac.21492. Epub 2018 Sep 12.
5
DNA methylation and repressive histones in the promoters of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, PD-L1, and galectin-9 genes in human colorectal cancer.人类结直肠癌中 PD-1、CTLA-4、TIM-3、LAG-3、TIGIT、PD-L1 和半乳糖凝集素-9 基因启动子中的 DNA 甲基化和抑制组蛋白
Clin Epigenetics. 2018 Aug 6;10(1):104. doi: 10.1186/s13148-018-0539-3.
6
Cancer epigenetics: Moving forward.癌症表观遗传学:展望未来。
PLoS Genet. 2018 Jun 7;14(6):e1007362. doi: 10.1371/journal.pgen.1007362. eCollection 2018 Jun.
7
Hypermethylation of the SPARC promoter and its prognostic value for prostate cancer.SPARC 启动子的高甲基化及其对前列腺癌的预后价值。
Oncol Rep. 2018 Feb;39(2):659-666. doi: 10.3892/or.2017.6121. Epub 2017 Nov 29.
8
Promoter hypermethylation may contribute to E‑cadherin repression in the human salivary carcinoma ex pleomorphic adenoma.启动子高甲基化可能导致人类唾液多形性腺瘤癌 ex 中的 E-钙黏蛋白抑制。
Int J Oncol. 2018 Feb;52(2):496-504. doi: 10.3892/ijo.2017.4210. Epub 2017 Nov 22.
9
H3K9ac and HDAC2 Activity Are Involved in the Expression of Monocarboxylate Transporter 1 in Oligodendrocyte.H3K9乙酰化和HDAC2活性参与少突胶质细胞中单羧酸转运体1的表达。
Front Mol Neurosci. 2017 Nov 14;10:376. doi: 10.3389/fnmol.2017.00376. eCollection 2017.
10
Human papillomaviruses in epigenetic regulations.人类乳头瘤病毒在表观遗传调控中的作用。
Mutat Res Rev Mutat Res. 2017 Apr-Jun;772:36-50. doi: 10.1016/j.mrrev.2016.09.006. Epub 2016 Sep 19.